food and drug administration fda - Search News

FDA bans red dye 3

Hosted on MSN · 1d

FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats

After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,

FDA Bans Red Dye 3 On Cusp Of Potentially Big Changes In Food Industry

FDA’s ban on Red 3 is a shot across the bow to the food sector that could ironically help facilitate Kennedy’s pursuit of further changes.

CNN on MSN · 3d

FDA bans red dye No. 3 from food, drinks and ingested drugs in the US

Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .

FDA approves 20 ZYN Nicotine pouches

USA TODAY on MSN · 1d

FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.

U.S. News & World Report · 1d

FDA Approves Marketing of Nicotine Pouches

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed to be placed between a person's gum and lip.

MarketWatch on MSN · 1d

Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.

AstraZeneca, Datroway and US FDA

Reuters on MSN · 19h

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

Business Insider · 19h

AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

MarketWatch · 20h

AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

18hon MSN

FDA orders manufacturers to do a better job detecting bird flu in raw pet food

FDA wants pet food manufacturers to do a better job identifying possible signs of bird flu in raw foods such as uncooked meat ...

3don MSN

New FDA proposal would put 'front-of-package' nutrition labels on food products

The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results